MedPath

Swedish Orphan Biovitrum AB (Publ)

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

44

Active:38
Completed:1

Trial Phases

2 Phases

Phase 1:24
Phase 4:1

Drug Approvals

17

EMA:7
FDA:6
NMPA:4

Drug Approvals

Anakinra injection

Product Name
安络定
Approval Number
国药准字SJ20230016
Approval Date
Oct 27, 2023
NMPA

Emapalumab Injection

Product Name
伽蜜芬
Approval Number
国药准字SJ20220008
Approval Date
Mar 8, 2022
NMPA

Emapalumab Injection

Product Name
伽蜜芬
Approval Number
国药准字SJ20220009
Approval Date
Mar 8, 2022
NMPA

Emapalumab Injection

Product Name
伽蜜芬
Approval Number
国药准字SJ20220010
Approval Date
Mar 8, 2022
NMPA

Clinical Trials

Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials

Phase 1
24 (96.0%)
Phase 4
1 (4.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.